|

18F-FDG Clinical Trials

14 actively recruiting trials across 4 locations

Also known as: 18F-FDG injection, CT scan, Intravenous injection of 18F-FDG with a dosage of approximately 3.7-5.55 MBq (0.1-0.15 mCi)/kg., PET scan, blood collection

Other10 trials

68Ga-FAPI-RGD PET/CT Imaging in the Lung Cancer Patients
Early 1
68Ga-RM26-RGD PET/CT Imaging in the GRPR and αvβ3 Positive Tumor Patients
Early 1
A Molecular Probe Targeting BCMA for the Clinical Diagnosis of Multiple Myeloma
Early 1
CD147 Targeting Nanobody Probe for PET Imaging in Solid Tumors
CLDN18.2 Targeting Nanobody Probe for PET Imaging in Solid Tumors
N/A
Dosimetry and Preliminary Clinical Application Study of a Novel Probe Targeting CD73
Early 1
Lung Nodule Detection Using Ultra-long FOV PET/CT
Phase 4
Nectin-4 Specific LMW PET Probe Imaging in Urothelial Carcinoma
N/A
PD-L1 Specific 68Ga-THP-PD-L1-3 Probe for PET Imaging in Solid Tumors
N/A
Research on Early Diagnosis and Clinical Transformation of Nuclide Probe Based on Bioorthogonal-gastric Cancer Mucin Target Visualization
N/A

Sacramento, California1 trial

NeuroFLiPP: Parametric PET of Neuroinflammation in Fatty Liver Disease

UC Davis EXPLORER Molecular Imaging Center

Early 1

Bethesda, Maryland1 trial

18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection

National Institutes of Health Clinical Center

Phase 2

Englewood, New Jersey1 trial

Ultralow Dose PET Imaging of 18F-FDG Uptake

Nuclear Imaging Institute

Phase 2

New York, New York1 trial

Cholesterol Lowering and Residual Risk in Diabetes, Type 1

New York VA Hospital

Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.